How to treat male breast cancer

(1) Modified radical resection is suitable for patients without pectoral muscle invasion.

(2) For patients with pectoral muscle invasion, radical resection or extended radical resection is the main surgical approach. Because tumors located in the areola area can easily metastasize to the inner breast area and axillary lymph nodes ； Therefore, if radiotherapy equipment is not available and there are contraindications to radiotherapy, extended radical resection is highly indicated. If you have the above equipment, you can consider radical surgery and additional postoperative radiotherapy, but be careful when choosing modified radical mastectomy for breast cancer. ； It is even more unsuitable to choose a procedure less than a simple mastectomy.

Male breast cancer has breast characteristics and a rich network of lymphatic vessels under the nipple and areola. If the tumor is small, lymph node metastasis will occur in the inner breast area or armpit. Therefore, postoperative radiotherapy to the internal mammary area, armpit, supraclavicular and chest wall is necessary. Radiotherapy treatment can be divided into: postoperative radiotherapy ； Preoperative radiotherapy ； Radiation therapy for tumor recurrence.

Preoperative additional chemotherapy for male breast cancer and postoperative chemotherapy for patients with positive lymph node metastasis and negative ER are expected to improve the survival rate. According to the theory of cytology, postoperative chemotherapy should be started early, generally no more than 1 month after surgery. If circumstances permit, chemotherapy should be continued within 1 year after surgery.

Mainly used for male breast cancer patients with advanced or recurrent breast cancer.

Male breast cancer patients are characterized by older age, longer disease course, and poor prognosis. However, if detected early and treated promptly, the prognosis will be the same as that of women. The factors that affect the prognosis of male breast cancer are mainly pathological type, stage, treatment method and the presence or absence of lymph node metastasis at the time of diagnosis.